Track Pardes Biosciences's current cash ($100M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2023), PRDS shows a current cash of $100M. That compares with $230M in the prior-year period — down 56.1% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PRDS's current cash is now $100M (was $230M) — a 56.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pardes Biosciences is outperforming or lagging.
Tracking PRDS's current cash over time shows whether Pardes Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $100M That compares with $230M in the prior-year period — down 56.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Pardes Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $100M) with ownership activity and broader fundamentals.